NANSAIDNon-Aspirin Non-Steroidal Anti-Inflammatory Drugs
References in periodicals archive ?
Recent reports suggest a reduced risk of Alzheimer's disease in people who take NANSAIDs.
The mechanism of action of NANSAIDs and aspirin is mediated by inhibition of prostaglandin synthesis through an interaction with the enzyme cyclo-oxygenase.
Benefits include a reduction in thrombo-embolic stroke--although with a possible increase of haemorrhagic stroke [33, 37]--and a reduction in myocardial infarction rates with NANSAIDs (although this has yet to be confirmed in a prospective study).